Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:01 pm Sale | 2024-01-25 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 0 0.000% | -3,978,540 (Position Closed) | Filing History |
| 2024-01-29 1:04 pm Purchase | 2023-12-31 | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 287,875,814 5.100% | 2,932,117 (+1.03%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Pfizer Inc. PFE | BlackRock Inc. BLK | 434,748,255 7.700% | -8,120,506 (-1.83%) | Filing History |
| 2024-01-19 4:20 pm Unchanged | 2024-01-16 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2024-01-10 4:12 pm Purchase | 2024-01-08 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 11.260% | 3,978,540 (New Position) | Filing History |
| 2023-10-27 4:01 pm Purchase | 2023-10-19 | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 6.260% | 1,272,214 (New Position) | Filing History |
| 2023-10-25 5:29 pm Unchanged | 2023-08-02 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 13.140% | 0 (Unchanged) | Filing History |
| 2023-10-18 4:27 pm Unchanged | 2023-10-12 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 15.400% | 0 (Unchanged) | Filing History |
| 2023-10-10 4:11 pm Unchanged | 2023-10-05 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2023-09-11 4:08 pm Unchanged | 2023-09-11 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2023-07-10 09:10 am Purchase | 2023-06-30 | 13G | Caribou Biosciences, Inc. CRBU | PFIZER INC PFE | 4,690,431 7.100% | 4,690,431 (New Position) | Filing History |
| 2023-05-15 4:45 pm Unchanged | 2023-05-11 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2023-03-30 5:02 pm Purchase | 2023-03-20 | 13G | Zura Bio Limited ZURA | PFIZER INC PFE | 2,970,022 10.780% | 2,970,022 (New Position) | Filing History |
| 2023-03-27 4:27 pm Unchanged | 2023-02-07 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 17.300% | 0 (Unchanged) | Filing History |
| 2023-03-23 4:20 pm Purchase | 2023-03-17 | 13G | Pyxis Oncology, Inc. PYXS | PFIZER INC PFE | 7,032,770 19.020% | 1,811,594 (+34.70%) | Filing History |
| 2023-02-13 5:14 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | PFIZER INC PFE | 5,221,176 14.880% | 2,229,654 (+74.53%) | Filing History |
| 2023-02-13 5:06 pm Purchase | 2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | PFIZER INC PFE | 1,362,499 7.020% | 1,362,499 (New Position) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Pfizer Inc. PFE | VANGUARD GROUP INC | 501,636,220 8.940% | 36,361,295 (+7.82%) | Filing History |
| 2023-02-07 1:11 pm Sale | 2022-12-31 | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 284,943,697 5.080% | -827,894 (-0.29%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Pfizer Inc. PFE | BlackRock Inc. BLK | 442,868,761 7.900% | 32,883,116 (+8.02%) | Filing History |